J.S.P. Yuen - Publications, H-index & Citations

J.S.P. Yuen

Singapore General Hospital

19H指数

85论文数

1.7K被引数

收录论文 13

发表时间

Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data 前列腺癌局部冷冻疗法后复发的转录组预测因子：一项II期试验和前瞻性队列数据的合并分析

Journal of the National Cancer Center

IF9.4

2025-05-29

OAAI

Kae Jack Tay; Boon Hao Hong; Enya Hui Wen Ong; Kah Min Tan; Gianella Cabuhat Pacho; Samantha Jingxuan Wong; Yu Guang Tan; Yan Mee Law; Nye Thane Ngo; Puay Hoon Tan; John S.P. Yuen; Henry S.S. Ho; Kenneth Chen; Jiping Peng; Clare Wei Tian Foo; Xin Xiu Sam; Jeffrey K.L. Tuan; Ravindran Kanesvaran; Rajan T. Gupta; Steven Rozen; Thomas J. Polascik; Yang Liu; James Proudfoot; Elai Davicioni; Li Yan Khor; Melvin Lee Kiang Chua

High genomic risk is associated with clinically significant prostate cancer (csPCa) recurrences following focal therapy (FT)高基因组风险与聚焦治疗后临床显著前列腺癌（csPCa）复发相关。

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Hong, B. H.; Tay, K. J.; Ong, E.; Tan, K. M.; Tan, Y. G.; Law, Y. M.; Ngo, N. T.; Tan, P. H.; Yuen, J. S. P.; Ho, H. S. S.; Chen, K.; Peng, J.; Tuan, J.; Kanesvaran, R.; Liu, Y.; Proudfoot, J. A.; Davicioni, E.; Khor, L. Y.; Chua, M. L. K.

Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial 术前前列腺动脉栓塞用于大于80 mL的前列腺腺体的经尿道前列腺电切术：首个随机对照试验

PROSTATE INTERNATIONAL

IF2.6

2024-11-01

OAAI

Alvin Y.M. Lee; Shu Hui Neo; Bellamy A. Brodie; Tze Kiat Ng; Edwin J. Aslim; Zong Yi Chin; Michael M. Ladera; Soon Hing Chong; Pradesh Kumar; Allen S.P. Sim; John S.P. Yuen; Sivanathan Chandramohan; Kenneth Chen

Local Therapy on Clinically Lymph Node-positive Prostate Cancer: A Systematic Review and Meta-analysis

EUROPEAN UROLOGY ONCOLOGY

IF9.3

2024-06-01

PREAI

Yaow, Clyve Yu Leon; Lee, Han Jie; Teoh, Seth En; Chong, Ryan Ian Houe; Ng, Tze Kiat; Tay, Kae Jack; Ho, Henry; Law, Yan Mee; Tuan, Jeffrey; Yuen, John; Chen, Kenneth

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning (Jan, 10.1038/s41391-021-00485-3, 2022)

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2022-02-28

OAAI

Lee, Alvin Y. M.; Chen, Kenneth; Tan, Yu Guang; Lee, Han Jie; Shutchaidat, Vipatsorn; Fook-Chong, Stephanie; Cheng, Christopher W. S.; Ho, Henry S. S.; Yuen, John S. P.; Ngo, Nye Thane; Law, Yan Mee; Tay, Kae Jack

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

2022-01-14

OAAI

Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy 多参数MRI超声软件融合前列腺活检: 使用立体定向机器人辅助经会阴前列腺活检平台比较系统和靶向活检的初步结果

BJU INTERNATIONAL

IF4.4

2020-09-14

PREAI

Lee, Alvin Y. M.; Yang, Xin Yan; Lee, Han Jie; Law, Yan Mee; Huang, Hong Hong; Lau, Weber K. O.; Lee, Lui Shiong; Ho, Henry S. S.; Tay, Kae Jack; Cheng, Christopher W. S.; Yuen, John S. P.; Chen, Kenneth

Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2 肿瘤抑制因子KDM6A的缺失会放大膀胱癌中PRC2-regulated的转录抑制，并且可以通过抑制EZH2来靶向

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2017-02-22

169

PREAI

Ler, Lian Dee; Ghosh, Sujoy; Chai, Xiaoran; Thike, Aye Aye; Heng, Hong Lee; Siew, Ee Yan; Dey, Sucharita; Koh, Liang Kai; Lim, Jing Quan; Lim, Weng Khong; Myint, Swe Swe; Loh, Jia Liang; Ong, Pauline; Sam, Xin Xiu; Huang, Dachuan; Lim, Tony; Tan, Puay Hoon; Nagarajan, Sanjanaa; Cheng, Christopher Wai Sam; Ho, Henry; Ng, Lay Guat; Yuen, John; Lin, Po-Hung; Chuang, Cheng-Keng; Chang, Ying-Hsu; Weng, Wen-Hui; Rozen, Steven G.; Tan, Patrick; Creasy, Caretha L.; Pang, See-Tong; McCabe, Michael T.; Poon, Song Ling; Teh, Bin Tean

Mutation signatures implicate aristolochic acid in bladder cancer development

GENOME MEDICINE

IF11.2

2015-04-28

OAAI

Poon, Song Ling; Huang, Mi Ni; Choo, Yang; McPherson, John R.; Yu, Willie; Heng, Hong Lee; Gan, Anna; Myint, Swe Swe; Siew, Ee Yan; Ler, Lian Dee; Ng, Lay Guat; Weng, Wen-Hui; Chuang, Cheng-Keng; Yuen, John S. P.; Pang, See-Tong; Tan, Patrick; Teh, Bin Tean; Rozen, Steven G.

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model

BRITISH JOURNAL OF CANCER

IF6.8

2011-03-15

OAAI

Yuen, J. S. P.; Sim, M. Y.; Siml, H. G.; Chong, T. W.; Lau, W. K. O.; Cheng, C. W. S.; Huynh, H.

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-06-10

OAAI

Yuen, John S. P.; Akkaya, Erdem; Wang, Yong; Takiguchi, Megumi; Peak, Sandra; Sullivan, Mark; Protheroe, Andrew S.; Macaulay, Valentine M.